RecruitingNCT06943157

Self-Efficacy and Medication Adherence in Patients With Coronary Artery Disease: A Descriptive Study

Investigation of the Relationship Between Self-Efficacy and Adherence to Medication in Individuals With Coronary Artery Disease: A Descriptive and Correlational Study


Sponsor

Hasan Kalyoncu University

Enrollment

135 participants

Start Date

Mar 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This descriptive study aims to examine the relationship between self-efficacy and medication adherence in individuals with coronary artery disease (CAD). The study will be conducted between March and October 2025 at Adıyaman University Training and Research Hospital with a planned sample size of 135 participants. Data will be collected using a Descriptive Information Form, the Self-Efficacy for Managing Chronic Disease Scale, and the Medication Adherence Report Scale (MARS).


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Being 18 years of age or older
  • Having been diagnosed with Coronary Artery Disease (angina pectoris, unstable angina, myocardial infarction) at least 1 year ago
  • Being followed
  • Being able to communicate in Turkish
  • Voluntarily agreeing to participate in the study
  • Having no diagnosed mental disorder

Exclusion Criteria3

  • Having a primary diagnosis other than Coronary Artery Disease
  • Being unable to complete the questionnaires due to mental health problems
  • Providing incomplete data or withdrawing from the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention

This is a descriptive, observational study. No intervention or experimental procedure was performed. Data were collected using self-administered questionnaires without influencing participant behavior or treatment.


Locations(1)

Adiyaman University Training and Research Hospital

Adıyaman, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06943157


Related Trials